Related Experiment Video
Updated: Jun 29, 2026

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
Published on: February 19, 2019
Analysis of Clinical Characteristics and Long-Term Prognosis in Young Patients with Hepatitis B Cirrhosis: A
Pengyue Zhang1,2, Wenjuan Zhang1,3, Xinlei Chen1,2
1Department of Infectious Diseases, The Second Hospital of Anhui Medical University, Hefei, People's Republic of China.
Background:
Cirrhosis is rare in young individuals, and clinical differences between young and adult patients remain unclear. This study aimed to evaluate the clinical characteristics and prognosis of HBV-related cirrhosis in young patients.
Methods:
A hospital-based retrospective cohort of young cirrhosis patients was analyzed. Multivariable analysis identified risk factors for severe complications during follow-up, while the Cox proportional-hazards model assessed the prognosis of young and adult patients with HBV-related cirrhosis. Prognosis was assessed after baseline covariates were balanced using propensity score matching (PSM).
Results:
The study included 545 patients with cirrhosis, including 119 in the younger group. Young patients with HBV-related cirrhosis exhibited significant differences from adult patients in gender, Alb, ALT, AST, and HBV titer. Kaplan-Meier analysis indicated a higher survival rate in the young group (P = 0.04); however, no significant difference remained after PSM. Youth was identified as an independent risk factor for gastrointestinal bleeding during follow-up (OR = 3.61, 95% CI: 1.62-8.00, P = 0.002). Additionally, age and elevated ALP levels were independent risk factors for survival. The Cox-based prediction model showed moderate prognostic performance, with a C-index of 0.69.
Conclusion:
After baseline differences were balanced, young patients with HBV-related cirrhosis showed no survival advantage. Vigilant monitoring for serious complications, particularly gastrointestinal bleeding, is warranted. These findings may inform targeted interventions to reduce the burden of early onset cirrhosis.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Hepatitis
Cirrhosis I: Introduction
Cirrhosis II: Pathophysiology

